Complete Phase-Out Stavudine Based Regimens in the Treatment of HIV-Infection: is it True That Stavudine Hasn’t Any Benefit Today? A Review
Journal: Journal of Epidemiology and Public Health Reviews (Vol.2, No. 5)Publication Date: 2017-10-06
Authors : Deus Buma Muhammad Bakari Wafaie Fawzi Ferdinand Mugusi;
Page : 1-5
Keywords : Phase-out stavudine; initiate-stop-initiate strategy;
Abstract
Change of Antiretroviral drugs (ARVs) in the management of HIV/AIDS is not uncommon. Phase-out of stavudine came with challenges in the low-income countries contrary to the developed ones. Much as stavudine was effective similar to other ARVs we reviewed studies that were used to provide evidence for phase out from 1990 to 2016. We noted that stavudine at low dose was effective compared to standard dose in terms of viral load suppression and immune recovery. The associated side effects were significantly alleviated and occurred at longer period when stavudine dose was given at equal to or less than 30mg per day whether given at single or divided doses. The findings provide evidence for its resumption and to be one of the important drugs for patients that cannot tolerate tenofovir, zidovudine or abacavir based combinations.
Other Latest Articles
- THE USE OF A FUZZY EXPERT SYSTEM TO INCREASE THE RELIABILITY OF DIAGNOSTICS OF AXLE BOXES OF ROLLING STOCKS
- LOGISTICS INFORMATION PROCESSING SYSTEMS ON THE THRESHOLD OF IoT
- ELECTROMAGNETIC LOCKING DEVICES OF CAR HANDLING UNITS
- PRIORITISATION OF FERRY COMMUTERS’ NEEDS IN LAGOS METROPOLIS: AN ANALYTICAL HIERARCHICAL PROCESS APPROACH
- ANALYSIS OF ROAD TRAFFIC SAFETY IN THE PIŁA POVIAT
Last modified: 2020-08-27 00:03:26